
New treatments in the management of type 2 diabetes: a critical appraisal of saxagliptin
Author(s) -
Baptist Gallwitz
Publication year - 2010
Publication title -
diabetes, metabolic syndrome and obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.853
H-Index - 43
ISSN - 1178-7007
DOI - 10.2147/dmso.s4857
Subject(s) - saxagliptin , incretin , dipeptidyl peptidase 4 inhibitor , metformin , medicine , pharmacology , tolerability , type 2 diabetes , glycemic , hypoglycemia , dipeptidyl peptidase 4 , diabetes mellitus , endocrinology , sitagliptin , adverse effect